NCT05116904

Smith Magenis Syndrome and Autism Spectrum Disorders

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2022-03-30Est. Completion: 2027-04

Enrollment target: 40 participants

Locations

Service Épilepsie-Sommeil-Explorations Fonctionnelles Neurologiques Pédiatriques Hôpital Femme-Mère-Enfant HCL, Bron, France
GénoPsy, Reference Center for Diagnosis and Management of Genetic Psychiatric Disorders, Centre Hospitalier le Vinatier and EDR-Psy Q19 Team (Centre National de la Recherche Scientifique & Lyon 1 Claude Bernard University), Bron, France

Contact

Patricia FRANCO, PhDpatricia.franco@chu-lyon.fr 0427856052

Other microbiome trials you might be interested in

Natural History Study of Smith-Magenis SyndromeCompleted

Smith-Magenis Syndrome (SMS)

This study will examine how a rare disease called Smith-Magenis syndrome (SMS) affects people and how they change over t…

Bethesda, United States

View Trial →

Parent and Infant Inter(X)Action Intervention (PIXI)ENROLLING_BY_INVITATION

Fragile X SyndromeAngelman SyndromePrader-Willi SyndromeDup15Q SyndromeDuchenne Muscular DystrophyPhelan-McDermid SyndromeRett SyndromeSmith Magenis SyndromeWilliams SyndromeTurner SyndromeKlinefelter Syndrome

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.